Tonix Pharmaceuticals Holding Corp
TNXP
Get informed when a big investor buys or sells
+ FollowMarket Cap$116.37M
Close$
$13.83
115.5% upside
Current Fair Value
115.5% upsideUndervalued by 115.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $116.37 Million |
|---|---|
| Enterprise Value | $-54,776,160.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-14.57 |
| Beta | 1.79 |
| Outstanding Shares | 16,635,254 |
Return
| Return on Equity | -50.73% |
|---|---|
| Return on Assets | -44.38% |
| Return on Invested Capital | -72.72% |
Valuation & Multiples
| P/E Ratio | -0.55 |
|---|---|
| PEG | - |
| Price to Sales | 6.42 |
| Price to Book Ratio | 0.49 |
| Enterprise Value to Revenue | -1.88 |
| Enterprise Value to EBIT | 0.34 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.09 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$-2.64
Average shareholder expectationRevenue Estimate
$7.72 M
Average shareholder expectationNext Earnings Call
Expected Date
November 9, 2026
EPS Estimate
$-2.45
Average shareholder expectationRevenue Estimate
$15.87 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 260.19% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.01%▼ 68.69% |
|---|---|
| Total Invested | $9,603▼ 99.99% |
| Investors Holding | 3▼ 106.00% |
ESG Score
No data
About Tonix Pharmaceuticals Holding Corp
CEO: Seth Lederman